CBOA
MDCO

Commonwealth Bank of Australia’s Medicines Co MDCO Stock Holding History

Commonwealth Bank of Australia’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-12,200
Closed -$347K – 1104
2014
Q1 		$347K Sell
12,200
-16,600
-58% -$549K ﹤0.01% 1123
2013
Q4 		$1.11M Sell
28,800
-2,300
-7% -$82.2K 0.01% 773
2013
Q3 		$1.04M Buy
31,100
+4,800
+18% +$153K 0.01% 741
2013
Q2 		$809K Buy
+26,300
New +$880K 0.01% 787

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Commonwealth Bank of Australia's MDCO Position: Q2 2014 in Review

Commonwealth Bank of Australia sold out of Medicines Co (MDCO) in Q2 2014, closing a stake of 12,200 shares — an estimated $347K sold.

Commonwealth Bank of Australia first reported a position in MDCO in Q2 2013 and held it in 4 quarters. The position peaked at $1.11M in Q4 2013. 152 funds tracked by Wall St. Rank hold MDCO as of Q2 2014.

  • Commonwealth Bank of Australia reported no remaining Medicines Co position as of Q2 2014 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 12,200 Medicines Co shares in Q2 2014, an estimated $347K.
  • Commonwealth Bank of Australia first reported a position in Medicines Co in Q2 2013 and held it in 4 quarters.
  • Commonwealth Bank of Australia's Medicines Co position peaked at $1.11M in Q4 2013.
  • 152 funds tracked by Wall St. Rank held Medicines Co as of Q2 2014.

Based on Commonwealth Bank of Australia's 13F filing for Q2 2014, filed 11 Aug 2014.